| pubmed-article:14615871 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C1513684 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C0311400 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C0599883 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C1555903 | lld:lifeskim |
| pubmed-article:14615871 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
| pubmed-article:14615871 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:14615871 | pubmed:dateCreated | 2003-12-23 | lld:pubmed |
| pubmed-article:14615871 | pubmed:abstractText | Schizophrenia is a heterogeneous syndrome both at the etiological and clinical levels. In particular, patients with schizophrenia exhibit important variability in their therapeutic and metabolic responses to clozapine, an antipsychotic medication. | lld:pubmed |
| pubmed-article:14615871 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14615871 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14615871 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14615871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14615871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14615871 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14615871 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:14615871 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:14615871 | pubmed:author | pubmed-author:JooberRidhaR | lld:pubmed |
| pubmed-article:14615871 | pubmed:author | pubmed-author:BaptistaTrino... | lld:pubmed |
| pubmed-article:14615871 | pubmed:author | pubmed-author:BoksaPatricia... | lld:pubmed |
| pubmed-article:14615871 | pubmed:author | pubmed-author:ZarateJean... | lld:pubmed |
| pubmed-article:14615871 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14615871 | pubmed:volume | 171 | lld:pubmed |
| pubmed-article:14615871 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14615871 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14615871 | pubmed:pagination | 162-72 | lld:pubmed |
| pubmed-article:14615871 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:meshHeading | pubmed-meshheading:14615871... | lld:pubmed |
| pubmed-article:14615871 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14615871 | pubmed:articleTitle | Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains. | lld:pubmed |
| pubmed-article:14615871 | pubmed:affiliation | Department of Neurology and Neurosurgery, McGill University and Douglas Hospital Research Centre, H4H 1R3, Montréal, Québec, Canada. | lld:pubmed |
| pubmed-article:14615871 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14615871 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:14615871 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:14615871 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
